on Pentixapharm Holding AG (isin : DE000A40AEG0)
Pentixapharm Holding AG Lists on Frankfurt Stock Exchange
Pentixapharm Holding AG has successfully launched its IPO on the Frankfurt Stock Exchange, marking its debut in the Prime Standard with a first trading price of EUR 5.10. The company's market capitalization opened at EUR 126.5 million. This move follows the spin-off from Eckert & Ziegler SE, finalized after the registration in the commercial register.
The biopharmaceutical firm focuses on radiopharmaceuticals for blood cancers and other indications. With funds from the IPO and a convertible bond from Eckert & Ziegler worth EUR 18.5 million, Pentixapharm aims to advance its growth strategy, prioritizing clinical development and approvals for its lead candidates, Ga68-PentixaFor and Y90-PentixaTher.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Pentixapharm Holding AG news